Uta Kiltz Selected Research

Therapeutics

11/2022	Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
1/2022	Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial.
12/2021	Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey.
1/2021	Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence.
1/2020	Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis.
1/2019	[Multi-Faceted Symptoms with Joint Pain, Exanthema and Eye Involvement].
1/2018	Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study.
1/2017	Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
3/2016	Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.
3/2015	Emerging drugs for the treatment of axial and peripheral spondyloarthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Uta Kiltz Research Topics

Disease

16	Axial Spondyloarthritis 11/2022 - 07/2013
16	Ankylosing Spondylitis 08/2022 - 09/2012
9	Psoriatic Arthritis 08/2022 - 03/2015
8	Pain (Aches) 01/2022 - 12/2016
7	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 03/2015
5	Inflammation (Inflammations) 01/2022 - 09/2012
4	Rheumatoid Arthritis 11/2022 - 03/2015
4	Necrosis 01/2022 - 01/2016
4	Non-Radiographic Axial Spondyloarthritis 01/2021 - 09/2012
3	Ankylosis 01/2022 - 12/2019
3	Fatigue 12/2020 - 07/2016
2	Uveitis 06/2022 - 01/2019
1	Connective Tissue Diseases (Connective Tissue Disease) 11/2022
1	Arthritis (Polyarthritis) 11/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022
1	COVID-19 01/2022
1	Hepatitis B 01/2021
1	Infections 01/2021
1	Human Influenza (Influenza) 01/2021
1	Measles 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Latent Tuberculosis 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Nasopharyngitis 01/2018
1	Sacroiliitis 06/2017
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2016
1	Reinfection 03/2016
1	Crohn Disease (Crohn's Disease) 03/2015

Drug/Important Bio-Agent (IBA)

8	secukinumabIBA 08/2022 - 03/2015
7	Biological ProductsIBA 11/2022 - 10/2017
7	Antirheumatic Agents (DMARD)IBA 06/2022 - 06/2017
7	C-Reactive ProteinIBA 01/2021 - 09/2012
5	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 07/2013
4	Adalimumab (Humira)FDA Link 01/2021 - 03/2015
3	Etanercept (Enbrel)FDA Link 01/2022 - 03/2015
3	Biosimilar PharmaceuticalsIBA 11/2021 - 03/2015
3	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2017
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2020
2	ixekizumabIBA 01/2022 - 01/2021
2	ametantrone (HAQ)IBA 11/2021 - 12/2020
2	CytokinesIBA 01/2021 - 03/2015
2	InterleukinsIBA 01/2021 - 03/2020
2	GlucocorticoidsIBA 06/2017 - 01/2016
2	Infliximab (Remicade)FDA Link 03/2016 - 03/2015
1	Pharmaceutical PreparationsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	GLPG0634IBA 01/2022
1	RA 25IBA 11/2021
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2021
1	AntibodiesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Prostaglandins AIBA 10/2017
1	N-phthaloylglutamic acidIBA 10/2017
1	Analgesics (Analgesic Drugs)IBA 06/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	golimumab FDA Link 03/2015
1	Interleukin-12 (IL 12)IBA 03/2015
1	Ustekinumab (CNTO 1275)FDA Link 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014

Therapy/Procedure

12	Therapeutics 11/2022 - 07/2013
3	Biological Therapy 10/2020 - 07/2013
1	Activities of Daily Living (ADL) 03/2020